Lu Cai
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Machine Learning in Bioinformatics 2
- RNA and protein synthesis mechanisms 2
- Angiogenesis and VEGF in Cancer 1
- Ubiquitin and proteasome pathways 1
- Oncology 5
- Cancer Cells and Metastasis 2
- Co-authors
- Fengfeng Cai (8 shared papers)Ewelina Biskup (6 shared papers)Minghong Wang (3 shared papers)Xiaoyan Lin (2 shared papers)Xiaoyan Lin (3 shared papers)Xin Pan (3 shared papers)Chen Su (2 shared papers)Cheng Xu (1 shared paper)
- Journals
- Oncotarget (2 papers)Current Problems in Cardiology (1 paper)Frontiers in Oncology (1 paper)Genomics (1 paper)Rejuvenation Research (1 paper)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Lu Cai
12 papers receiving 302 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 85
- Cardiology and Cardiovascular Medicine 62
- Oncology 74
- Toxicology 7
- Molecular Biology 125
Countries citing papers authored by Lu Cai
This map shows the geographic impact of Lu Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Cai more than expected).
Fields of papers citing papers by Lu Cai
This network shows the impact of papers produced by Lu Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Cai. The network helps show where Lu Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 119 | |
| 2 | 2021 | 62 | |
| 3 | 2016 | 49 | |
| 4 | 2011 | 18 | |
| 5 | 2017 | 15 | |
| 6 | 2017 | 13 | |
| 7 | 2019 | 9 | |
| 8 | 2014 | 8 | |
| 9 | 2019 | 6 | |
| 10 | 2024 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2017 | 1 |
About Lu Cai
Lu Cai is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 12 papers that have together received 305 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Machine Learning in Bioinformatics (2 papers), Cancer Cells and Metastasis (2 papers), RNA and protein synthesis mechanisms (2 papers), Virus-based gene therapy research (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (85 citations), Cardiology and Cardiovascular Medicine (62 citations), Oncology (74 citations), Toxicology (7 citations) and Molecular Biology (125 citations). Lu Cai has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Fengfeng Cai, Ewelina Biskup, Minghong Wang, Xiaoyan Lin, Xiaoyan Lin, Xin Pan, Chen Su, Cheng Xu, Yuan Wan and Yu‐An Huang. Their work appears in journals such as Oncotarget, Current Problems in Cardiology, Frontiers in Oncology, Genomics and Rejuvenation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.